A NOVEL TRANSGENIC MOUSE MODEL FOR SYSTEMIC SCLEROSIS WITH BALANCED UPREGULATION OF TGF beta SIGNALING PATHWAYS
CP Denton(The Royal Free Hospital), Casilda G. Black, LA Evans, Shiwen Xu(Northeast Agricultural University), Dietmar Abraham(Medical University of Vienna)
UCL Discovery (University College London)
April 1, 2003
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Raf-1-associated Protein Phosphatase 2A as a Positive Regulator of Kinase Activation
|Journal of Biological Chemistry|2000|219
Endothelin-1 Induces Expression of Matrix-associated Genes in Lung Fibroblasts through MEK/ERK
|Journal of Biological Chemistry|2004|170